CIK: 1236368 - Address: 320 Wakara Way, Salt Lake City, UT 84108
23 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1110-1-1-3-21121
S%wins60507060603055

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/16/19 16:16
12/13/19
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDP15025.60061254D
6/7/18 16:00
6/5/18
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDM.dm73224.3903027D
6/7/18 16:00
6/5/18
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDS.dm-1,19139.690-30-5227D
12/15/17 15:09
12/14/17
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDS-24933.190-8-2227D
12/14/15 15:46
12/11/15
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDS-21142.2330-5-2913D75203474-4-3-4120-14-28-58
2/26/14 18:18
2/26/14
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDM.d73224.4033300D635136326239224-20-13-9-3-5
2/26/14 18:18
2/26/14
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDS.d-1,12737.5833-30-1000D635136326239224-20-13-9-3-5
2/20/14 17:31
2/19/14
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDM.d1,28921.4833600D47402730642571233113-7
2/20/14 17:31
2/19/14
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDS.d-2,06934.4833-60-1000D47402730642571233113-7
8/21/12 17:55
8/20/12
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDM.dm78213.0320600D65401334656-3-4718-210
8/21/12 17:55
8/20/12
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDS.dm-1,55925.9920-60-1000D65401334656-3-4718-210
9/8/08 16:31
9/5/08
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDM.d25725.7433100D149417634-1-3-2-7-21-8-6216
9/8/08 16:31
9/5/08
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDS.d-63363.3133-10-1000D149417634-1-3-2-7-21-8-6216
11/6/07 18:42
11/5/07
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDM.d9017.863350D1769637236-33-5-7-9-8-24-2433
11/6/07 18:42
11/5/07
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDS.d-26752.9733-5-1000D1769637236-33-5-7-9-8-24-2433
11/6/07 18:42
11/5/07
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDM57819.2933300D1769637236-33-5-7-9-8-24-2433
11/6/07 18:42
11/5/07
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDS-1,58652.9233-30-1000D1769637236-33-5-7-9-8-24-2433
5/9/07 10:59
5/9/07
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDM.d32110.7033300D131354371166-3-1-3-512375
5/9/07 10:59
5/9/07
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDS.d-1,14238.0533-30-1000D131354371166-3-1-3-512375
11/13/06 10:38
11/9/06
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDS.m-97026.9921-36-1000M38446111415-33811263675
3/9/06 15:48
3/7/06
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDM.dm63311.52205536b15-5-3-629
3/9/06 15:48
3/7/06
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticGilbert Walter PhdUTDS.dm-1,42525.9120-55-6036b15-5-3-629
9/23/05 18:04
9/23/05
MEMYMemory Pharmaceuticals CorpHealthDrugPharmaceutical PreparationsGilbert Walter PhdNJDP.d1001.9005339186I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact